GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
34.05 EGP -0.85-2.436%
As of 05 AUG 2021 12:29 GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.361%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
16.06 14 JAN
44.9 07 FEB

Open
35.97 EGP
Previous Close
34.90 EGP
Turnover
421.04K EGP
EPS
-
Volume
12,268
Transactions
55
Market Cap
2.91B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.Last updated on: 15 January 2018

Business Summary
Manufacture of branded and generic drugs, chemicals, veterinary, vitamins and nutritional products, pharmaceutical and bulk drugs substance.
Country of Incorporation
Ownership Type
Established In
1981
Primary Sector
Number of Employees
1000
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Building: Boomerang Building 46, Block J
Street: Ninety Street
Floor: 1st-3rd Floor
Area: 5th Settlement
P.O. Box: 41
Country: Egypt
City: Cairo
City Suffix: 11835
CONTACT
  • Tel: +20 2-2618-5000
  • Fax: +20 2-2618-5001
Region
Cairo
More
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Amro Mohammed Mamdouh Abdulmajid
Managing Director
Dr Ashraf Mohammed Ibrahim Mansour
Medical and Regulatory Director
Mr Amro Abou Naja
Marketing Director

Board Members

Dr Amro Mohammed Mamdouh Abdulmajid
Chairman and director representing GlaxoSmithkline Plc
Dr Ashraf Mohammed Ibrahim Mansour
Director director representing GlaxoSmithkline Plc
Mr Jude Albert Brajanza
Director representing GlaxoSmithkline Plc
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.38.100 EGP-0.105
EGYPT INTL PHRM46.750 EGP-0.848
ALX. PHARMACEUT.134.000 EGP-0.763
MINAPHARM PHARMA98.510 EGP-0.635
ARAB PHARM62.530 EGP-1.559
More

Thursday Outlook: Dollar bounces back; Asian shares hold ground

Thursday Outlook: Dollar bounces back; Asian shares hold ground

Remarks from U.S. Fed Reserve official signals possibility of bringing forward policy tightening

More

Most Viewed Stocks

Stock Screener

More